Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
Capsules3 mg
Similar Products
RIVASTIGMINA ARENA 3 mg
Cholinesterase inhibitor indicated in the treatment of Alzheimer's type dementia
Active Substance (INN)
RIVASTIGMINUM
Packaging
3,4,11 bl x 10 caps
Adverse Reaction Reporting
To report an adverse reaction, please contact us using the email address below and provide all relevant information.
informatii.medicale@arenagroup.ro
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.